AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Regul Integr Comp Physiol 243: R312-R317, 1982;
0363-6119/82 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ritter, S.
Right arrow Articles by Ladenheim, E. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ritter, S.
Right arrow Articles by Ladenheim, E. E.

AJP - Regulatory, Integrative and Comparative Physiology, Vol 243, Issue 3 312-R317, Copyright © 1982 by American Physiological Society

ARTICLES

Glucoprivic feeding is impaired by lateral or fourth ventricular alloxan injection

S. Ritter, J. M. Murnane and E. E. Ladenheim

Feeding and blood glucose responses to insulin and 2-deoxy-D-glucose (2-DG) were examined in rats previously given lateral or fourth ventricular injections of the diabetogenic agents, alloxan and streptozotocin. Although streptozotocin (120, 200, and 400 micrograms) was ineffective, lateral ventricular alloxan injections (40 micrograms in 5 microliters) reduced feeding to 45% of control after 350 mg/kg 2-DG (sc), 33% of control after 150 mg/kg 2-DG, and 65% of control after insulin (2 U/kg). Fourth ventricular alloxan injections produced greater deficits, reducing feeding to 19, 7, and 46% of control, respectively. The sympathoadrenal response to glucoprivic agents was normal after alloxan treatment; however, blood glucose levels fell more rapidly during fasting than in controls. Alloxan-induced deficits did not appear to result from damage to catecholamine neurons, since neither regional concentrations nor glucoprivation-induced elevation of catecholamine turnover was altered by alloxan pretreatment. We conclude that cells involved in the glucoprivic control of feeding can be selectively and permanently damaged by intracerebroventricular alloxan administration. Such cells appear to reside in the hindbrain, to be noncatecholaminergic, and to function independently of glucoreceptors mediating sympathodrenal discharge.


This article has been cited by other articles:


Home page
 Physiol. Rev.Home page
L. A. Campfield and F. J. Smith
Blood Glucose Dynamics and Control of Meal Initiation: A Pattern Detection and Recognition Theory
Physiol Rev, January 1, 2003; 83(1): 25 - 58.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
B. E. Levin, A. A. Dunn-Meynell, and V. H. Routh
Brain glucose sensing and body energy homeostasis: role in obesity and diabetes
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 1999; 276(5): R1223 - R1231.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online